semaglutide blindness study May Be Linked to Condition That Causes Ozempic, Wegovy may be linked

Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials

doi:10.1016/j.cmet.2021.09.001 [Elsevier] Chen P, Poddar R, Tipa EV, et al

How GLP-1 Works in the Body Im excited to share how GLP-1 works in the body and why its so effective

Accessed at ncbi.nlm.nih.gov/books/NBK501847 on May 31, 2024

What can be said: animal studies show measurable tissue changes beginning in the first 1-2 weeks, with the most significant structural improvements at 3-6 weeks